Real-World Study of PADN for the Treatment of PAH

Pulnovo Medical

Status: Enrolling

Conditions: Hypertension, Pulmonary Arterial; Pulmonary Hypertension

Treatments: Device: Enhancor™ Radiofrequency Catheter, Pulnovo Medical (Wuxi) CO., Ltd., Wuxi, Jiangsu, China

Study type: Observational

Funder types: Industry

Identifiers

NCT07039604

PADN-PMS

Details and patient eligibility

About

Real-World Study of PADN for the Treatment of PAH

Enrollment: 200 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Diagnosed with PAH and received PADN procedure since March 2024.
2. No contraindications to procedure.
3. Able to provide informed consent and authorize use of health/research data.
4. Compliant with treatment and follow-up requirements.

Exclusion criteria

None specified.